Contrast Media Market

The report "Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031" The global contrast media market is projected to reach USD 12.08 billion by 2031 from USD 7.65 billion in 2025, at a CAGR of 7.9% from 2026 to 2031. The contrast media market is mainly driven by innovation in contrast agent formulas and the introduction of targetable and activatable contrast agents, which enhance the accuracy of imaging studies and meet the increasing demand for precise diagnostics. Additionally, government investments in healthcare initiatives, such as programs to expand diagnostic imaging services and framework agreements, support access to advanced imaging. Moreover, the rising burden of chronic diseases like cancer and cardiovascular conditions necessitates contrast imaging studies for early detection, monitoring, and treatment planning.

Browse 250 market data Tables and 80 Figures spread through 300 Pages and in-depth TOC on "Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/contrast-media-market-911.html

The iodinated contrast media segment is expected to register a significant growth rate over the forecast period of 2026-2031

By type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media. The iodinated contrast media segment had the highest CAGR in 2026. Since iodinated contrast media are commonly used in numerous CT, MRI, ultrasound, and mammography procedures in hospitals and diagnostic centers, it is expected to have the highest CAGR. The increasing use of this product is driven by its widespread clinical acceptance, high imaging performance, and compatibility with the latest CT technology. Ongoing product modifications aimed at reducing toxicity and enhancing patient safety are further boosting demand. Additionally, global demand for iodinated contrast agents is growing rapidly, fueled by the expansion of cardiac and vascular imaging.

The oral route segment accounted for the largest share of the contrast media market by route of administration in 2026.

By route of administration, the contrast media market is segmented into intravascular, oral, rectal, and other routes. The oral route dominates the contrast media market because it is the most common method in gastrointestinal imaging procedures, mainly for examining the stomach, intestines, and other abdominal organs. It is preferred for its non-invasiveness, ease of use, and greater patient-friendliness compared to injectable options. Additionally, oral contrast agents help reduce the risk of side effects associated with intravenous agents. Furthermore, oral contrast agents are an affordable alternative and can be easily used for routine diagnostic scans, which explains their widespread use in healthcare centers.
 
The hospitals, clinics, and ambulatory surgery centers segment accounted for the largest share of the contrast media market, by end user, in 2026

By end user, the contrast media market is divided into hospitals, clinics, ambulatory surgery centers, and diagnostic imaging centers. In 2026, hospitals, clinics, ambulatory surgery centers, and diagnostic imaging centers held the largest share of the contrast media market. These end users result from the high volume of diagnostic and interventional imaging procedures they perform daily. These institutions have advanced CT, MRI, and angiography equipment, which are seeing a higher proportion of contrast-mediated scans across various clinical specialties. Increased patient visits to emergency care and chronic disease management also contribute to steady demand from these end users.

The Asia Pacific market is expected to register the highest growth during the forecast period.

The Asia Pacific contrast media market is expected to experience the highest growth from 2026 to 2031. One of the main reasons is the rising healthcare expenditure and the ongoing improvement of diagnostic infrastructure in countries like China and India. Market growth is further supported by increased awareness of early disease detection and better access to advanced imaging facilities in semi-urban and rural areas. Additionally, factors such as a large patient population, supportive policies, the growth of the medical tourism industry, and the opening of new private hospitals and diagnostic centers are driving higher demand for contrast and enhanced imaging procedures.

As of 2026, prominent players in the contrast media market are Bracco Imaging S.p.A. (Italy), Bayer AG (Germany), Guerbet (US), Lantheus Medical Imaging (US), GE HealthCare (US),  Unijules Life Sciences Ltd. (India), J.B. Chemicals & Pharmaceuticals Limited (India), Sanochemia Pharmazeutika GmbH (Germany), Taejoon Pharm Co., Ltd. (South Korea), Jodas Expoim (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Beijing Beilu Pharmaceutical Co., Ltd. (China), and Livealth Biopharma Pvt. Ltd. (India) among others.

Don’t miss out on business opportunities in Contrast Media Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com